| scholarly article | Q13442814 |
| P50 | author | Wolfram Ruf | Q88984483 |
| Claudine Graf | Q90196799 | ||
| P2093 | author name string | Maki Kitano | |
| Petra Wilgenbus | |||
| Federico Marini | |||
| Hartmut Weiler | |||
| Stephan Macher-Göppinger | |||
| Sabine Reyda | |||
| Jennifer Pott | |||
| Sven Pagel | |||
| P2860 | cites work | Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo | Q24312071 |
| Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity | Q24312864 | ||
| Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity | Q24617126 | ||
| Clinical pharmacokinetic and pharmacodynamic profile of rivaroxaban | Q26864411 | ||
| Endothelial protein C receptor function in murine and human breast cancer development | Q27327182 | ||
| Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected | Q28084627 | ||
| Protease-activated receptor 2 signalling promotes dendritic cell antigen transport and T-cell activation in vivo | Q28511351 | ||
| Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm | Q29614349 | ||
| Macrophage diversity enhances tumor progression and metastasis | Q29615847 | ||
| Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages | Q29620142 | ||
| Pooling across cells to normalize single-cell RNA sequencing data with many zero counts. | Q31086305 | ||
| Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R | Q31154742 | ||
| Efficient generation of germ line transmitting chimeras from C57BL/6N ES cells by aggregation with outbred host embryos | Q33617812 | ||
| Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. | Q33621624 | ||
| An Immune Atlas of Clear Cell Renal Cell Carcinoma | Q33649707 | ||
| Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer. | Q33759372 | ||
| Antiangiogenic activity of the cleaved conformation of the serpin antithrombin | Q33874343 | ||
| Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor | Q33901970 | ||
| Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2. | Q33924308 | ||
| p38 MAPK controls prothrombin expression by regulated RNA 3' end processing | Q34025620 | ||
| Tissue factor-protease-activated receptor 2 signaling promotes diet-induced obesity and adipose inflammation. | Q34226558 | ||
| CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. | Q34279134 | ||
| The cellular and molecular origin of tumor-associated macrophages | Q34378833 | ||
| Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. | Q34429912 | ||
| A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). | Q34465280 | ||
| Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. | Q34541646 | ||
| The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. | Q34568612 | ||
| CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells | Q35567056 | ||
| EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. | Q35584261 | ||
| Identification of cell types from single-cell transcriptomes using a novel clustering method. | Q35585889 | ||
| Coagulation factor V mediates inhibition of tissue factor signaling by activated protein C in mice | Q36301525 | ||
| Inhibition of tissue factor signaling suppresses tumor growth | Q36384586 | ||
| PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells | Q36647485 | ||
| The plasminogen fibrinolytic pathway is required for hematopoietic regeneration | Q37106230 | ||
| The CD8+ dendritic cell subset | Q37700814 | ||
| Metabolic origins of spatial organization in the tumor microenvironment. | Q37711597 | ||
| Multiple roles of the coagulation protease cascade during virus infection | Q37723466 | ||
| Tissue factor and cell signalling in cancer progression and thrombosis | Q37903955 | ||
| Tumor-associated macrophages: from mechanisms to therapy | Q38230880 | ||
| Innate Immunity and Mobilization of Hematopoietic Stem Cells | Q38606202 | ||
| A pathology atlas of the human cancer transcriptome | Q38619228 | ||
| Neutrophils in cancer: neutral no more. | Q38860382 | ||
| The Multifaceted Role of Perivascular Macrophages in Tumors | Q38895474 | ||
| Tumour-associated macrophages as treatment targets in oncology. | Q39100693 | ||
| Endothelial protein C receptor is required for tissue factor ternary complex signaling in the mouse | Q39540209 | ||
| Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. | Q39704661 | ||
| Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII. | Q40224109 | ||
| New insights into the multidimensional concept of macrophage ontogeny, activation and function. | Q40866271 | ||
| Macrophage receptor SR-AI is crucial to maintain normal plasma levels of coagulation factor X. | Q41096078 | ||
| Structural insight into allosteric modulation of protease-activated receptor 2. | Q42152331 | ||
| Identification of the coagulation factor VIIa integrin binding site required for pro-angiogenic PAR2 signaling | Q47287709 | ||
| Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism | Q47682974 | ||
| Paraoxonase-2 regulates coagulation activation through endothelial tissue factor. | Q50028342 | ||
| PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression. | Q50031872 | ||
| Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. | Q50048634 | ||
| Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1. | Q51821860 | ||
| Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance. | Q52644782 | ||
| The Platelet Lifeline to Cancer: Challenges and Opportunities. | Q52719266 | ||
| CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. | Q55053710 | ||
| Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy | Q57293731 | ||
| Protease-activated receptor-2 signalling by tissue factor on dendritic cells suppresses antigen-specific CD4+ T-cell priming | Q58836876 | ||
| Activation of CD8⁺ T Cell Responses after Melanoma Antigen Targeting to CD169⁺ Antigen Presenting Cells in Mice and Humans | Q62589146 | ||
| Studies in a tumor spectrum. I. Comparison of the action of methylbis (2-chloroethyl)amine and 3-bis(2-chloroethyl)aminomethyl-4-methoxymethyl -5-hydroxy-6-methylpyridine on the growth of a variety of mouse and rat tumors | Q75985578 | ||
| Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response | Q88511733 | ||
| Apixaban to Prevent Venous Thromboembolism in Patients with Cancer | Q90240985 | ||
| Expression of factor V by resident macrophages boosts host defense in the peritoneal cavity | Q91709762 | ||
| In vivo behavior of human radioiodinated antithrombin III: distribution among three physiologic pools | Q93569506 | ||
| P433 | issue | 39 | |
| P921 | main subject | coagulation factor x human | Q28859740 |
| P577 | publication date | 2019-09-01 | |
| P1433 | published in | Science Immunology | Q27727580 |
| P1476 | title | Myeloid cell-synthesized coagulation factor X dampens antitumor immunity | |
| P478 | volume | 4 |
| Q98183378 | Coagulation signaling and cancer immunotherapy | cites work | P2860 |
Search more.